Jiangsu Lianhuan Pharmaceutical Co., Ltd.

¥12.86As of Sun 8 Nov 2026, 12:00 UTC
SSE:600513Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.90%
Div yield 0.54%
ROE (2.18%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.11)
PE TTM —
TSR TTM (40.65%)
Mkt cap ¥3.671B
ROIC (0.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
4.13%
(42.67%)
Buy 8|0|5|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.19
0.21
0.22
21.51%
24.98%
30.42%
22.32%
Revenue¥M
170.0
173.3
175.1
183.7
9.44%
12.99%
12.52%
13.67%
Peers (US$550.3M)
Cap (US$)
PE
548.8M
19.00x
552.2M
149.0x
Capital
TTM
5Y
10Y
Leveragex
1.202
0.098
0.095
EBIT/Intx
1.182
0.041
0.045
Own earn%
116.03
(32.25)
(47.04)
Sh yield%
33.91
60.38
58.59
Owners
Insiders/Inst%
3.42
81.69
Short interest%
5.06
SBC / revenue%
5.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
30–36
$1 testx
—
Incr. ROIC%
3